Тритечный Профилактика Метаболического Синдрома У Мужчин
Keywords:
Метаболический синдром (МС) ИМТ, артериальная гипертензия, гиперлипидемия и гиперинсулинемия
Abstract
Метаболическому синдрому (МС) в основе которого лежит инсулинорезистентность. Этот синдром включает ряд факторов риска (ФР): артериальную гипертензию (АГ), НТГ, дислипопротеидемию (ДЛП), ожирение, гиперурекемию и другие факторы риска. Следует отметить, что в отдельных исследованиях количество компонентов, включаемых в МС различается. Вместе с тем, АГ, ИМТ, гиперлипидемия и гиперинсулинемия остаются основными компонентами МС.
References
1. Mohammad G. Saklayen. The Global Epidemic of the Metabolic Syndrome Curr Hypertens Rep. 2018; 20(2): 12. Published online 2018 Feb 26. doi: 10.1007/s11906-018-0812-z PMCID: PMC5866840
2. National Center for Health Statistics, Division of Health Interview Statistics. Crude and age-adjusted percentage of civilian, noninstitutionalized adults with diagnosed diabetes, United States, 1980–2010. National Center for Chronic Disease Prevention and Health Promotion, Ed. Atlanta, GA, Centers for Disease Control and Prevention, Division of Diabetes Translation, 2012.
3. Palaniappan LP, Wong EC, Shin JJ, et al. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. In J Obe. 2017;35:393–400. doi: 10.1038/ijo.2010.152. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Wang Y, Mi J, Shan X, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obesity. 2007;31:177–188. doi: 10.1038/sj.ijo.0803354. [PubMed] [CrossRef] [Google Scholar] 2015 Obesity collaborators GBD. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; [PMC free article] [PubMed]
5. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004), 2008. Arch Int Med. 168:1617–24. [PubMed]
6. Firmann M, Mayor V, Vidal PM, et al. The CoLaus study: a population based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6. doi: 10.1186/1471-2261-8-6.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Ogurtsova K, Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinicalpractice. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024. [PubMed] [CrossRef] [Google Scholar]
8. Delvari A, Forouanafar MH, Alikhani S et al. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East. [PMC free article] [PubMed]
9. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. doi: 10.1038/nature14177.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Ferguson-Smith AC, Patti ME. You are what your dad ate. Cell Metab. 2011;13(2):115–117. doi: 10.1016/j.cmet.2011.01.011. [PubMed] [CrossRef] [Google Scholar]
11. Heijjmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008;105(44):17046–17049. doi: 10.1073/pnas.0806560105. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017;2:2000143. doi: 10.1136/bmjsem-2016-000143.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Hofmann T, Elbelt U, Stengel A. Irisin as a muscle-derived hormone stimulates thermogenesis-a critical update. Peptide. 2014;54:89–100. doi: 10.1016/j.peptides.2014.01.016.[PubMed] [CrossRef] [Google Scholar]
14. Yang Q, Cogswell ME, Flanders WD, et al., Trends in cardiovascular health metrics and association with all cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–1283. doi: 10.1001/jama.2012.339.
2. National Center for Health Statistics, Division of Health Interview Statistics. Crude and age-adjusted percentage of civilian, noninstitutionalized adults with diagnosed diabetes, United States, 1980–2010. National Center for Chronic Disease Prevention and Health Promotion, Ed. Atlanta, GA, Centers for Disease Control and Prevention, Division of Diabetes Translation, 2012.
3. Palaniappan LP, Wong EC, Shin JJ, et al. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. In J Obe. 2017;35:393–400. doi: 10.1038/ijo.2010.152. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Wang Y, Mi J, Shan X, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obesity. 2007;31:177–188. doi: 10.1038/sj.ijo.0803354. [PubMed] [CrossRef] [Google Scholar] 2015 Obesity collaborators GBD. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; [PMC free article] [PubMed]
5. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004), 2008. Arch Int Med. 168:1617–24. [PubMed]
6. Firmann M, Mayor V, Vidal PM, et al. The CoLaus study: a population based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6. doi: 10.1186/1471-2261-8-6.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Ogurtsova K, Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinicalpractice. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024. [PubMed] [CrossRef] [Google Scholar]
8. Delvari A, Forouanafar MH, Alikhani S et al. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East. [PMC free article] [PubMed]
9. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. doi: 10.1038/nature14177.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Ferguson-Smith AC, Patti ME. You are what your dad ate. Cell Metab. 2011;13(2):115–117. doi: 10.1016/j.cmet.2011.01.011. [PubMed] [CrossRef] [Google Scholar]
11. Heijjmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008;105(44):17046–17049. doi: 10.1073/pnas.0806560105. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017;2:2000143. doi: 10.1136/bmjsem-2016-000143.[PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Hofmann T, Elbelt U, Stengel A. Irisin as a muscle-derived hormone stimulates thermogenesis-a critical update. Peptide. 2014;54:89–100. doi: 10.1016/j.peptides.2014.01.016.[PubMed] [CrossRef] [Google Scholar]
14. Yang Q, Cogswell ME, Flanders WD, et al., Trends in cardiovascular health metrics and association with all cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–1283. doi: 10.1001/jama.2012.339.
Published
2022-02-02
How to Cite
Ш. К., Б., А, К. Х., Б. , Р. Б., & Б, Р. И. (2022). Тритечный Профилактика Метаболического Синдрома У Мужчин. Central Asian Journal of Medical and Natural Science, 3(1), 109-114. https://doi.org/10.17605/cajmns.v3i1.568
Section
Articles
